Current NHS consultant posts held
Burton Hospitals NHS Foundation Trust
Research interests
Dr Ahmad is the Principal Investigator for Burton Hospitals NHS FT for the UKCLRN Haematology trials. His other interests include Patient safety and
Patient experience.
Personal interests
Dr Ahmad is an advocate for patient safety and has a specialist interest in prevention of blood clots. He holds a Master of Science Degree (MSc) in Medical Leadership and actively promotes clinical engagement in improving healthcare systems and patient safety.
Awards received
Health and Social Care Award (Patient Safety WMR) 2009
Doctor of the Year Award (Burton Hospitals NHS FT 2013)
(Additional) Languages spoken
Publications
Late discovery of a case with TAR syndrome who presented with an additional potential bleeding risk, other than thrombocytopenia. Authors: B. Van Staden, H.N. Ahmad. BJH:2013, 161 (Suppl. 1)
Two case studies showing the importance of Coumarin tracing blood assays to investigate acquired coagulopathies in patients with self harm behaviour. Authors: H.N. Ahmad, B. Van Staden, J. Channa, D Harrington. BJH 2013, 161 (Suppl. 1)
Smaller fixed doses of prothrombin complex concentrate are effective for reversal of warfarin over-anticoagulation and reduce costs significantly: results of a retrospective audit in the settings of a district general hospital. Authors: H.N.Ahmad, K. Sharma, B. Van Staden. BJH: 2012,157 (Suppl. 1)
Successful establishment of a traceability system for blood product transfusion surveillance using the DiaMed gel station plus analyser and its interface with Meditech electronic patient record in the setting of a UK district general hospital. Authors: Jeby Jeyachandran, Trudi Burton, Mark, Adams, Malcolm West, Lora Morris, Humayun Ahmad. Int.Jnl.Lab.Hem.2012, 34 (Suppl.1),
Inpatient Enoxaparin followed by outpatient Rivaroxaban use in elective hip and knee arthroplasty: a successful strategy for extended thromboprophylaxis
Authors: H N Ahmad, P Madahar, L Nancarrow, R Heatherley, V Venugopal, F Egbuonu,
F Amjad, N Ford, M Wallace; Haematologica June 2012; 97(s1): abst. 0481
Smaller fixed doses of prothrombin complex concentrate are effective for reversal of warfarin related over-anticoagulation and reduce costs significantly: Results of a retrospective audit in the settings of a district general hospital
Authors: H N Ahmad, K Sharma, B Van Staden
British Journal of Haematology, April 2012 157, (Suppl 1), abst. 095
Successful implementation of an electronic model of mandatory risk assessment for venous thromboembolism in patients admitted to a medium sized district general hospital,
Authors: H N Ahmad, Nick Ford, Petula Paul, Daniel Fudulu, Rahim Kanji
Haematologica Vol 96/S2 2011
Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence.
Authors: Else, M., Dearden, C. E., Matutes, E., Forconi, F., Lauria, F., Ahmad, H., Kelly, S., Liyanage, A., Ratnayake, V., Shankari, J., Whalley, I., Catovsky, D. LEUKEMIA & LYMPHOMA, 52. pp. 75-78. 2011
Courses offered to GPs
Interpretation of common blood tests;
Warfarin management;
VTE management
